{"transactions":[{"id":4628953,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-02T21:53:32.000Z","date":"2026-09-30","kind":"sale","planned":true,"acquired":false,"shares":75000,"price":25.4622,"value":1909665.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $25.0000 to $25.8201. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":528621,"source":{"system":"sec-edgar","filing":"0001933414-26-000121","document":"wk-form4_1790978009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1933414/000193341426000121/wk-form4_1790978009.xml","form_type":"4"}},{"id":708791,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-16T00:58:14.000Z","date":"2026-07-13","kind":"sale","planned":true,"acquired":false,"shares":10700,"price":27.2375,"value":291441.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on January 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $26.80 to $27.58. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":603621,"source":{"system":"sec-edgar","filing":"0001933414-26-000100","document":"wk-form4_1784163491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341426000100/wk-form4_1784163491.xml","form_type":"4"}},{"id":713487,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-07-07T20:05:10.000Z","date":"2026-07-05","kind":"grant","planned":false,"acquired":true,"shares":25370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in monthly increments over a period of one year from the grant date."}],"balance_after":25370,"derivative":{"exercise_price":14.8,"expiration_date":"2036-07-05","underlying":"Common Stock","underlying_shares":25370},"source":{"system":"sec-edgar","filing":"0001193805-26-000928","document":"e665631_4-congleton.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380526000928/e665631_4-congleton.xml","form_type":"4"}},{"id":722569,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-30T22:41:25.000Z","date":"2026-06-30","kind":"sale","planned":true,"acquired":false,"shares":17000,"price":26.8174,"value":455895.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $26.6450 to $26.8200. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":614321,"source":{"system":"sec-edgar","filing":"0001933414-26-000096","document":"wk-form4_1782859282.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341426000096/wk-form4_1782859282.xml","form_type":"4"}},{"id":722568,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-30T22:41:25.000Z","date":"2026-06-30","kind":"sale","planned":true,"acquired":false,"shares":58000,"price":25.9432,"value":1504705.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $25.5600 to $26.5000. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":631321,"source":{"system":"sec-edgar","filing":"0001933414-26-000096","document":"wk-form4_1782859282.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341426000096/wk-form4_1782859282.xml","form_type":"4"}},{"id":723881,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-29T20:34:34.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":50740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock conditionally approved by the Board of Directors on March 27, 2026, subject to approval of an amendment to the Company's 2019 Omnibus Equity Incentive Plan, as amended, by the Company's stockholders, which approval was obtained at the Company's 2026 Annual Meeting of Stockholders held on June 29, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in thirty-six (36) equal installments on each monthly anniversary of March 27, 2026."}],"balance_after":50740,"derivative":{"exercise_price":10.9,"expiration_date":"2036-03-27","underlying":"Common Stock","underlying_shares":50740},"source":{"system":"sec-edgar","filing":"0001193805-26-000892","document":"e665612_4-congleton.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380526000892/e665612_4-congleton.xml","form_type":"4"}},{"id":795315,"issuer":{"id":4662,"kind":"organization","name":"Avalyn Pharma Inc.","symbol":"AVLN"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-01T22:32:47.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":26978,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option vest and become exercisable on September 12, 2025, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":26978,"derivative":{"exercise_price":18,"expiration_date":"2036-04-28","underlying":"Common Stock","underlying_shares":26978},"source":{"system":"sec-edgar","filing":"0001193125-26-201875","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540171/000119312526201875/ownership.xml","form_type":"4"}},{"id":808036,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-16T01:45:20.000Z","date":"2026-04-13","kind":"sale","planned":true,"acquired":false,"shares":15730,"price":26.8264,"value":421979.272,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $26.81 to $26.96. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":689321,"source":{"system":"sec-edgar","filing":"0001933414-26-000075","document":"wk-form4_1776303917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341426000075/wk-form4_1776303917.xml","form_type":"4"}},{"id":818863,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-02T22:54:42.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":453,"price":27.0511,"value":12254.1483,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $27.0000 to $27.1000. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."}],"balance_after":705051,"source":{"system":"sec-edgar","filing":"0001644975-26-000004","document":"wk-form4_1775170480.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000164497526000004/wk-form4_1775170480.xml","form_type":"4"}},{"id":818862,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-02T22:54:42.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":55183,"price":26.5385,"value":1464474.0455,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $26.0000 to $26.9999. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":705504,"source":{"system":"sec-edgar","filing":"0001644975-26-000004","document":"wk-form4_1775170480.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000164497526000004/wk-form4_1775170480.xml","form_type":"4"}},{"id":818861,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-02T22:54:42.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":19364,"price":25.5006,"value":493793.6184,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $25.0000 to $25.9994. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":760687,"source":{"system":"sec-edgar","filing":"0001644975-26-000004","document":"wk-form4_1775170480.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000164497526000004/wk-form4_1775170480.xml","form_type":"4"}},{"id":890201,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2026-02-21T00:47:45.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":187900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant"}],"balance_after":187900,"derivative":{"exercise_price":28.06,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":187900},"source":{"system":"sec-edgar","filing":"0001933414-26-000045","document":"wk-form4_1771634862.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341426000045/wk-form4_1771634862.xml","form_type":"4"}},{"id":890200,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-21T00:47:45.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":140900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting. The RSUs vest in annual installments over a period of four years, with 1/4th of the total shares underlying the RSU vesting on each one-year anniversary of the date of grant."}],"balance_after":780051,"source":{"system":"sec-edgar","filing":"0001933414-26-000045","document":"wk-form4_1771634862.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341426000045/wk-form4_1771634862.xml","form_type":"4"}},{"id":939895,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-14T01:43:42.000Z","date":"2026-01-12","kind":"sale","planned":true,"acquired":false,"shares":7117,"price":33.1505,"value":235932.1085,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on January 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $32.8439 to $33.5000. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":639151,"source":{"system":"sec-edgar","filing":"0001644975-26-000002","document":"wk-form4_1768355020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000164497526000002/wk-form4_1768355020.xml","form_type":"4"}},{"id":939894,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-14T01:43:42.000Z","date":"2026-01-12","kind":"sale","planned":true,"acquired":false,"shares":9119,"price":32.2083,"value":293707.4877,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on January 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $31.8400 to $32.8028. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":646268,"source":{"system":"sec-edgar","filing":"0001644975-26-000002","document":"wk-form4_1768355020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000164497526000002/wk-form4_1768355020.xml","form_type":"4"}},{"id":989630,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2025-11-24T22:07:17.000Z","date":"2025-11-21","kind":"exercise","planned":false,"acquired":false,"shares":24082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Due to a rounding error, the exercise price for this stock option was originally reported as $0.53 per share on the Reporting Person's Form 3 filed on February 9, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested with respect to 25% of the underlying shares on March 12, 2022 and the remaining shares in 36 substantially equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":0.54,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":24082},"source":{"system":"sec-edgar","filing":"0001644975-25-000006","document":"wk-form4_1764022035.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000164497525000006/wk-form4_1764022035.xml","form_type":"4"}},{"id":989629,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-24T22:07:17.000Z","date":"2025-11-21","kind":"exercise","planned":false,"acquired":true,"shares":24082,"price":0.54,"value":13004.28,"ownership":{"direct":true},"balance_after":655387,"source":{"system":"sec-edgar","filing":"0001644975-25-000006","document":"wk-form4_1764022035.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000164497525000006/wk-form4_1764022035.xml","form_type":"4"}},{"id":999817,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-14T00:01:30.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":32850,"price":46.8862,"value":1540211.67,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.4400 to $47.4191. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6) to this Form 4."}],"balance_after":631305,"source":{"system":"sec-edgar","filing":"0001933414-25-000151","document":"wk-form4_1763078487.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341425000151/wk-form4_1763078487.xml","form_type":"4"}},{"id":999816,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-14T00:01:30.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":112275,"price":45.8335,"value":5145956.2125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $45.4300 to $46.4200. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."}],"balance_after":664155,"source":{"system":"sec-edgar","filing":"0001933414-25-000151","document":"wk-form4_1763078487.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341425000151/wk-form4_1763078487.xml","form_type":"4"}},{"id":999815,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-14T00:01:30.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":29207,"price":45.2003,"value":1320165.1621,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.4800 to $45.4297. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."}],"balance_after":776430,"source":{"system":"sec-edgar","filing":"0001933414-25-000151","document":"wk-form4_1763078487.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341425000151/wk-form4_1763078487.xml","form_type":"4"}},{"id":999814,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-14T00:01:30.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":43.4959,"value":173983.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.1700 to $44.0500. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":805637,"source":{"system":"sec-edgar","filing":"0001933414-25-000151","document":"wk-form4_1763078487.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341425000151/wk-form4_1763078487.xml","form_type":"4"}},{"id":999813,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-14T00:01:30.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":8862,"price":42.3095,"value":374946.789,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.0500 to $43.0400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":809637,"source":{"system":"sec-edgar","filing":"0001933414-25-000151","document":"wk-form4_1763078487.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341425000151/wk-form4_1763078487.xml","form_type":"4"}},{"id":999812,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-14T00:01:30.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":12806,"price":41.6395,"value":533235.437,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.0500 to $42.0000. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":818499,"source":{"system":"sec-edgar","filing":"0001933414-25-000151","document":"wk-form4_1763078487.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341425000151/wk-form4_1763078487.xml","form_type":"4"}},{"id":1018251,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-15T23:04:33.000Z","date":"2025-10-13","kind":"sale","planned":true,"acquired":false,"shares":1552,"price":43.0299,"value":66782.4048,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on  January 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.9822 to $43.2030. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":831305,"source":{"system":"sec-edgar","filing":"0001933414-25-000129","document":"wk-form4_1760569470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341425000129/wk-form4_1760569470.xml","form_type":"4"}},{"id":1018250,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-15T23:04:33.000Z","date":"2025-10-13","kind":"sale","planned":true,"acquired":false,"shares":13548,"price":42.6295,"value":577544.466,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on  January 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.9800 to $42.9800. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":832857,"source":{"system":"sec-edgar","filing":"0001933414-25-000129","document":"wk-form4_1760569470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341425000129/wk-form4_1760569470.xml","form_type":"4"}},{"id":1087215,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-15T21:02:38.000Z","date":"2025-07-11","kind":"sale","planned":true,"acquired":false,"shares":15884,"price":14.5071,"value":230430.7764,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on  January 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.30 to $14.73. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":846405,"source":{"system":"sec-edgar","filing":"0001933414-25-000078","document":"wk-form4_1752613354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341425000078/wk-form4_1752613354.xml","form_type":"4"}},{"id":1171611,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-16T00:33:35.000Z","date":"2025-04-11","kind":"sale","planned":true,"acquired":false,"shares":15319,"price":12.1942,"value":186802.9498,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on  January 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.0200 to $12.4087. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":862289,"source":{"system":"sec-edgar","filing":"0001933414-25-000044","document":"wk-form4_1744763608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341425000044/wk-form4_1744763608.xml","form_type":"4"}},{"id":1248847,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2025-02-24T23:58:52.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":570000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month anniversary following the date of grant."}],"balance_after":570000,"derivative":{"exercise_price":10.2,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":570000},"source":{"system":"sec-edgar","filing":"0001933414-25-000014","document":"wk-form4_1740441525.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341425000014/wk-form4_1740441525.xml","form_type":"4"}},{"id":1302273,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-16T02:44:54.000Z","date":"2025-01-13","kind":"sale","planned":true,"acquired":false,"shares":18333,"price":9.0592,"value":166082.3136,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $8.65 to $9.37. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":877608,"source":{"system":"sec-edgar","filing":"0001933414-25-000003","document":"wk-form4_1736995487.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341425000003/wk-form4_1736995487.xml","form_type":"4"}},{"id":1386471,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-10-15T20:21:57.000Z","date":"2024-10-11","kind":"sale","planned":true,"acquired":false,"shares":15271,"price":13.518,"value":206433.378,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $13.35 to $13.76. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":895941,"source":{"system":"sec-edgar","filing":"0001933414-24-000045","document":"wk-form4_1729023711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341424000045/wk-form4_1729023711.xml","form_type":"4"}},{"id":1455148,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-07-12T20:36:46.000Z","date":"2024-07-11","kind":"sale","planned":true,"acquired":false,"shares":15746,"price":13.3415,"value":210075.259,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.96 to $13.76. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":911212,"source":{"system":"sec-edgar","filing":"0001933414-24-000033","document":"wk-form4_1720816599.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341424000033/wk-form4_1720816599.xml","form_type":"4"}},{"id":1472763,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-20T21:44:01.000Z","date":"2024-06-20","kind":"sale","planned":true,"acquired":false,"shares":14940,"price":11.7294,"value":175237.236,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.525 to $12.05."}],"balance_after":926958,"source":{"system":"sec-edgar","filing":"0001933414-24-000032","document":"wk-form4_1718919832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341424000032/wk-form4_1718919832.xml","form_type":"4"}},{"id":1472762,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-20T21:44:01.000Z","date":"2024-06-18","kind":"sale","planned":true,"acquired":false,"shares":16607,"price":11.9873,"value":199073.0911,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.76 to $12.12."}],"balance_after":941898,"source":{"system":"sec-edgar","filing":"0001933414-24-000032","document":"wk-form4_1718919832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341424000032/wk-form4_1718919832.xml","form_type":"4"}},{"id":1472761,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-20T21:44:01.000Z","date":"2024-06-17","kind":"sale","planned":true,"acquired":false,"shares":17766,"price":12.2544,"value":217711.6704,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.0982 to $12.4627. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."}],"balance_after":958505,"source":{"system":"sec-edgar","filing":"0001933414-24-000032","document":"wk-form4_1718919832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341424000032/wk-form4_1718919832.xml","form_type":"4"}},{"id":1478459,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-14T22:15:49.000Z","date":"2024-06-14","kind":"sale","planned":true,"acquired":false,"shares":16229,"price":12.5185,"value":203162.7365,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.39 to $12.635."}],"balance_after":976271,"source":{"system":"sec-edgar","filing":"0001933414-24-000029","document":"wk-form4_1718403341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341424000029/wk-form4_1718403341.xml","form_type":"4"}},{"id":1478458,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-14T22:15:49.000Z","date":"2024-06-13","kind":"sale","planned":true,"acquired":false,"shares":39961,"price":12.7381,"value":509027.2141,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.49 to $13.04."}],"balance_after":992500,"source":{"system":"sec-edgar","filing":"0001933414-24-000029","document":"wk-form4_1718403341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341424000029/wk-form4_1718403341.xml","form_type":"4"}},{"id":1478457,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-14T22:15:49.000Z","date":"2024-06-12","kind":"sale","planned":true,"acquired":false,"shares":16607,"price":12.7665,"value":212013.2655,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.4587 to $13.35. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."}],"balance_after":1032461,"source":{"system":"sec-edgar","filing":"0001933414-24-000029","document":"wk-form4_1718403341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341424000029/wk-form4_1718403341.xml","form_type":"4"}},{"id":1640532,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-02-15T21:26:00.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":425000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total number of shares of Common Stock subject to the option on the first anniversary of the grant date, and as to 1/48th of  the total number of shares of Common Stock subject to the option on each monthly anniversary thereafter."}],"balance_after":425000,"derivative":{"exercise_price":14.25,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":425000},"source":{"system":"sec-edgar","filing":"0001628280-24-005064","document":"wk-form4_1708032345.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000162828024005064/wk-form4_1708032345.xml","form_type":"4"}},{"id":1729349,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-11-27T21:01:13.000Z","date":"2023-11-22","kind":"purchase","planned":false,"acquired":true,"shares":4250,"price":5.9661,"value":25355.925,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is the weighted-average purchase price, purchased in multiple transactions at prices ranging from $5.8850 to $5.9996. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":1049068,"source":{"system":"sec-edgar","filing":"0001933414-23-000093","document":"wk-form4_1701118862.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341423000093/wk-form4_1701118862.xml","form_type":"4"}},{"id":1784456,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-08T12:49:26.000Z","date":"2023-09-06","kind":"purchase","planned":false,"acquired":true,"shares":2250,"price":12.08,"value":27180.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is the weighted-average purchase price, purchased in multiple transactions at prices ranging from $11.9860 to $12.1202. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":1044818,"source":{"system":"sec-edgar","filing":"0001933414-23-000067","document":"wf-form4_169417735412478.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341423000067/wf-form4_169417735412478.xml","form_type":"4"}},{"id":1800449,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-21T20:03:20.000Z","date":"2023-08-17","kind":"purchase","planned":false,"acquired":true,"shares":2250,"price":12.1,"value":27225.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is the weighted-average purchase price, purchased in multiple transactions at prices ranging from $12.02 to $12.1473. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":1042568,"source":{"system":"sec-edgar","filing":"0001933414-23-000065","document":"wf-form4_169264818560082.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341423000065/wf-form4_169264818560082.xml","form_type":"4"}},{"id":1809505,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-11T23:11:15.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":12.89,"value":25780.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is the weighted-average purchase price, purchased in multiple transactions at prices ranging from $12.8522 to $12.9257. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":1040318,"source":{"system":"sec-edgar","filing":"0001933414-23-000061","document":"wf-form4_169179546088184.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341423000061/wf-form4_169179546088184.xml","form_type":"4"}},{"id":1942647,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-03-21T22:48:09.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":99800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total number of shares of Common Stock subject to the option on the first anniversary of the grant date, and as to 1/48th of  the total number of shares of Common Stock subject to the option on each monthly anniversary thereafter."}],"balance_after":99800,"derivative":{"exercise_price":15.44,"expiration_date":"2033-03-17","underlying":"Common Stock","underlying_shares":99800},"source":{"system":"sec-edgar","filing":"0001933414-23-000021","document":"wf-form4_167943887821849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000193341423000021/wf-form4_167943887821849.xml","form_type":"4"}},{"id":2019382,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-02-14T02:01:45.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":250046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total number of shares of Common Stock subject to the option on the first anniversary of the grant date, and as to 1/48th of  the total number of shares of Common Stock subject to the option on each monthly anniversary thereafter."}],"balance_after":250046,"derivative":{"exercise_price":16,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":250046},"source":{"system":"sec-edgar","filing":"0001628280-23-003425","document":"wf-form4_167634009091121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644975/000162828023003425/wf-form4_167634009091121.xml","form_type":"4"}},{"id":4603077,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":30285,"kind":"person","name":"Congleton Jon","position":1,"cik":"0001644975","reported_name":"Congleton Jon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-14T16:15:48.000Z","date":"2016-09-12","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable over a four-year period, with 25% vesting on the first anniversary of the grant date (September 12, 2017) and 1/48th of the options vesting monthly thereafter."}],"balance_after":250000,"derivative":{"exercise_price":7.77,"expiration_date":"2026-09-12","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-16-144630","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1626199/000110465916144630/a4.xml","form_type":"4"}}]}